PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SLNO vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


SLNONVDA
YTD Return41.74%198.17%
1Y Return157.68%214.54%
3Y Return (Ann)69.10%69.20%
5Y Return (Ann)21.99%95.71%
Sharpe Ratio2.674.20
Sortino Ratio3.204.08
Omega Ratio1.381.53
Calmar Ratio1.668.03
Martin Ratio12.9425.31
Ulcer Index12.37%8.58%
Daily Std Dev59.99%51.73%
Max Drawdown-99.86%-89.73%
Current Drawdown-91.31%-0.84%

Fundamentals


SLNONVDA
Market Cap$2.46B$3.62T
EPS-$2.79$2.13
PEG Ratio0.001.15
Total Revenue (TTM)$3.45M$78.19B
Gross Profit (TTM)$1.97M$59.77B
EBITDA (TTM)-$133.09M$52.02B

Correlation

-0.50.00.51.00.1

The correlation between SLNO and NVDA is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

SLNO vs. NVDA - Performance Comparison

In the year-to-date period, SLNO achieves a 41.74% return, which is significantly lower than NVDA's 198.17% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%20.00%40.00%60.00%JuneJulyAugustSeptemberOctoberNovember
33.24%
63.34%
SLNO
NVDA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SLNO vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SLNO
Sharpe ratio
The chart of Sharpe ratio for SLNO, currently valued at 2.67, compared to the broader market-4.00-2.000.002.004.002.67
Sortino ratio
The chart of Sortino ratio for SLNO, currently valued at 3.20, compared to the broader market-4.00-2.000.002.004.006.003.20
Omega ratio
The chart of Omega ratio for SLNO, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for SLNO, currently valued at 1.66, compared to the broader market0.002.004.006.001.66
Martin ratio
The chart of Martin ratio for SLNO, currently valued at 12.94, compared to the broader market0.0010.0020.0030.0012.94
NVDA
Sharpe ratio
The chart of Sharpe ratio for NVDA, currently valued at 4.20, compared to the broader market-4.00-2.000.002.004.004.20
Sortino ratio
The chart of Sortino ratio for NVDA, currently valued at 4.08, compared to the broader market-4.00-2.000.002.004.006.004.08
Omega ratio
The chart of Omega ratio for NVDA, currently valued at 1.53, compared to the broader market0.501.001.502.001.53
Calmar ratio
The chart of Calmar ratio for NVDA, currently valued at 8.03, compared to the broader market0.002.004.006.008.03
Martin ratio
The chart of Martin ratio for NVDA, currently valued at 25.31, compared to the broader market0.0010.0020.0030.0025.31

SLNO vs. NVDA - Sharpe Ratio Comparison

The current SLNO Sharpe Ratio is 2.67, which is lower than the NVDA Sharpe Ratio of 4.20. The chart below compares the historical Sharpe Ratios of SLNO and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00JuneJulyAugustSeptemberOctoberNovember
2.67
4.20
SLNO
NVDA

Dividends

SLNO vs. NVDA - Dividend Comparison

SLNO has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


TTM20232022202120202019201820172016201520142013
SLNO
Soleno Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%1.94%

Drawdowns

SLNO vs. NVDA - Drawdown Comparison

The maximum SLNO drawdown since its inception was -99.86%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for SLNO and NVDA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-91.31%
-0.84%
SLNO
NVDA

Volatility

SLNO vs. NVDA - Volatility Comparison

The current volatility for Soleno Therapeutics, Inc. (SLNO) is 9.38%, while NVIDIA Corporation (NVDA) has a volatility of 11.26%. This indicates that SLNO experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
9.38%
11.26%
SLNO
NVDA

Financials

SLNO vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items